logo

For the Inventor, By the Inventor

Havertown, PA, United States of America

Arthur Attilio Santilli

This inventor holds 47 USPTO granted patents, plus 1 CIPO patent, primarily in Estrogenic Agents. Top assignees: American Home Products Corporation, Wyeth, Other. Active years: 1976-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Arthur Attilio Santilli. Retrieved from https://idiyas.com/inventor/arthur-attilio-santilli

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 47

% Patents Active = 83.0

 

Average Co-Inventor Count = 3.2

ph-index = 11

Forward Citations = 417(Granted Patents)


Location History:

  • Havertwon, PA (US) (2002)
  • Havertown, PA (US) (1976 - 2010)

Company Filing History:

goldMedal30 out of 1,567 
 
American Home Products Corporation
 patents
silverMedal11 out of 1,309 
 
Wyeth
 patents
bronzeMedal6 out of 834,659 
Other
 patents

Years Active: 1976-2010

Loading Chart...
Loading Chart...
Areas of Expertise:
Estrogenic Agents
Cyclic Amides
Antiosteoporotic Compounds
Pyrrolobenzodiazepines
Thiazole Derivatives
Cyclic Urea
Tissue Selective Compounds
Indoles
Aminoalkoxyphenyl
Thieno-Fused Heterocycles
Cyclocarbamate
Benzoyl Indoles
47 patents (USPTO):Explore Patents
1. 7678787 - Pyrrolobenzodiazepine pyridine carboxamides and derivatives as follicle-stimulating hormone receptor antagonists (2010-03-16),
2. 7550456 - Substituted aryl cycloalkanoyl derivatives and methods of their use (2009-06-23),
3. 7449455 - 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents (2008-11-11),
4. 7365076 - Substituted aryl cycloalkanol derivatives and methods of their use (2008-04-29),
5. 7247624 - 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents (2007-07-24),
6. 7132417 - 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents (2006-11-07),
7. 7041663 - 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents (2006-05-09),
8. 6951852 - 2-Phenyl-1-[4-(2-Aminoethoxy)-Benzyl]-Indoles as estrogenic agents (2005-10-04),
9. 6924281 - 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents (2005-08-02),
10. 6835729 - 2-phenyl-1-[4(2-aminoethoxy)-benzyl]-indoles as estrogenic agents (2004-12-28),
11. 6787538 - 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents (2004-09-07),
12. 6441019 - Cyclocarbamate and cyclic amide derivatives (2002-08-27),
13. 6399593 - Cyclic regimens using cyclic urea and cyclic amide derivatives (2002-06-04),
14. 6380185 - N-substituted benzoyl indoles as estrogenic agents (2002-04-30),
15. 6380178 - Cyclic regimens using cyclocarbamate and cyclic amide derivatives (2002-04-30),

Title: The Innovative Mind of Arthur Attilio Santilli

Introduction: Arthur Attilio Santilli, a talented inventor hailing from Havertown, PA, is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Arthur Attilio Santilli holds several patents in various technological domains, showcasing his continuous dedication to pushing the boundaries of what is possible.

Career Highlights: Throughout his illustrious career, Arthur Attilio Santilli has demonstrated a keen ability to transform innovative ideas into tangible solutions that have a lasting impact on society. His work has revolutionized the way we interact with technology on a daily basis.

Collaborations: Arthur Attilio Santilli has collaborated with leading experts in the industry, fostering a culture of creativity and excellence that has led to numerous successful projects and inventions.

Conclusion: Arthur Attilio Santilli's passion for innovation and his relentless pursuit of excellence make him a true pioneer in the world of technology, inspiring generations to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…